WeightWatchers is acquiring Sequence, a digital health company offering $99/month telehealth visits with doctors who can prescribe weight loss drugs, for $106M
WeightWatchers is moving beyond its established weight-management offering by buying Sequence's clinician-led telehealth service. The deal places it alongside digital weight-care specialists: Found had already built an app-based service with telehealth and later raised a $100M Series B, while Noom had raised funding for its direct-to-consumer coaching app.
First-order effects
WeightWatchers gains Sequence's $99-per-month telehealth visits and the ability for its doctors to prescribe weight-loss drugs, adding clinical access to its consumer weight-management business.
Sequence becomes part of WeightWatchers rather than an independent telehealth provider, giving its service access to WeightWatchers' customer base and brand.
Second-order effects
Found and Noom face a larger branded rival that combines consumer weight management with telehealth prescribing, increasing pressure to distinguish their own coaching and care offerings.
The acquisition makes clinician access a more central competitive feature in digital weight care, rather than an add-on to app-based coaching alone.
Third-order effects
If similar combinations persist, digital weight-care providers will increasingly compete as integrated programs spanning behavior coaching, subscriptions, and clinician-mediated treatment, favoring companies that can assemble all three.
Acquisitions may become a primary route for established consumer health brands to add regulated care capabilities instead of building telehealth operations internally, echoing Fitbit's earlier purchase of Twine Health's coaching-and-doctor platform.
The trend: Consumer weight-management brands are consolidating with telehealth providers to pair engagement programs with access to clinician-led treatment.
a bit surprising PE firms are not doing tons of these combinations https://www.wsj.com/... trusted (but washed) legacy brand with a bit of distribution & lift on online ad engagements (discount on auction ad prices) + parallel higher margin online product/service
Weight-Watchers is buying digital health company Sequence, marking the diet company's move into the hot market for diabetes and obesity drugs including Ozempic. 👀 https://www.wsj.com/...
WeightWatchers is buying a digital health company that prescribes drugs like Ozempic, in a clear sign of what a threat these new medications pose to the traditional weight-loss industry. https://www.wsj.com/... via @WSJ
Super excited @ww_us is moving into the telehealth #weight management space with purchase of @joinsequence, a telemedicine platform with access to clinicians who specialize in the pharmacological treatment of obesity. The future is bright! https://www.wsj.com/...
$WW moves into concierge telehealth and the controversial market for diabetes and obesity drugs including Ozempic, Wegovy, Rybelsis https://www.wsj.com/... via @WSJ
News from @andreaapetersen: WeightWatchers is buying Sequence, a subscription service that offers telehealth visits with doctors who can prescribe Ozempic and Wegovy. “This is the biggest innovation in our industry today,” said WW's CEO of the drugs https://www.wsj.com/...